Categories Cancer

Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research

Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research NEW YORK–(BUSINESS WIRE)–Volastra Therapeutics today announced it will collaborate with Microsoft to develop tools that help detect drivers of cancer metastasis. These unique digital pathology tools will accelerate the development of promising new therapies for cancer and help identify the patients most likely to benefit. […]

Read More
HealthClot Feature Image
Categories Cancer

Overview of The Current Progress of Facultative Anaerobic Bacteria in Cancer Biotherapy with TNF …

Overview of The Current Progress of Facultative Anaerobic Bacteria in Cancer Biotherapy with TNF … [unable to retrieve full-text content] This review article focuses on the use of infectious bacteria as delivery tool for tumour necrosis factor alpha, a well-studied cytokine, in the context of …Published at Tue, 06 Apr 2021 11:15:14 +0000

Read More
Categories Multiple Myeloma

MitoImmune Received FDA Clearance of IND Application for MIT-001, a Novel Anti-Inflammatory …

MitoImmune Received FDA Clearance of IND Application for MIT-001, a Novel Anti-Inflammatory … – MitoImmune initiates a Phase 2 trial of oral mucositis (OM) prevention in the first half of 2021 in the US and Korea, and is expanding OM treatment into hematopoietic stem cell transplantation clinical trials SEOUL, South Korea, April 6, 2021 /PRNewswire/ […]

Read More
Categories Multiple Myeloma

Whole-Genome Sequencing Shows Ability to Identify Progressive Myeloma Precursor

Whole-Genome Sequencing Shows Ability to Identify Progressive Myeloma Precursor In a cohort of patients with monoclonal gammopathy of undetermined significance (MGUS) or smoldering myeloma, whole-genome sequencing (WGS) identified disease-defining genomic events that successfully identified 2 distinct precursors of multiple myeloma that may be able to stratify individuals as having either progressive or stable disease entities.1 […]

Read More
Categories Cancer

End-of-life care remains aggressive for people with ovarian cancer

End-of-life care remains aggressive for people with ovarian cancer People with ovarian cancer frequently receive aggressive end-of-life care despite industry guidelines that emphasize quality of life for those with advanced disease, according to a recent study. In fact, by 2016, ICU stays and emergency department visits in the last month of life had become more […]

Read More
Categories Cancer

Arvinas Announces Upcoming Presentations at the American Association for Cancer Research …

Arvinas Announces Upcoming Presentations at the American Association for Cancer Research … NEW HAVEN, Conn., April 05, 2021 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced two upcoming presentations at the American Association for Cancer Research (AACR) Annual Meeting […]

Read More
Categories Multiple Myeloma

GenomeFrontier, Ziopharm Non-Viral Vectors Could Transform CAR-T Cell Therapy

GenomeFrontier, Ziopharm Non-Viral Vectors Could Transform CAR-T Cell Therapy Ziopharm Chief Medical Officer Dr. Raffaele Baffa/Photo courtesy of Ziopharm Chimeric antigen receptor (CAR-T) therapy is one of the biggest cancer therapy breakthroughs of our time, but as with any precise science, there is still some fine-tuning to be done to overcome safety risks, limited payload […]

Read More
Categories Multiple Myeloma

HEMA-4 Screening Tool Predicts Survival in Older Patients With Malignant Hemopathies

HEMA-4 Screening Tool Predicts Survival in Older Patients With Malignant Hemopathies A newly developed screening tool, HEMA-4, effectively predicted survival among older patients with malignant hemopathies. These findings, from a prospective study, were published in the Journal of Geriatric Oncology. This study was conducted to develop and validate a simple score to estimate survival in […]

Read More